Latest Posts › Patent Applications

Share:

USPTO Announces Further Extension of Certain Patent Deadlines for Small and Micro Entities

In a notice posted on its website earlier today, the U.S. Patent and Trademark Office announced that it was further extending the time to file certain patent-related documents and to pay certain required fees, but only for...more

USPTO Announces Extension of Certain Patent Deadlines

In a USPTO Alert distributed March 31[i], the U.S. Patent and Trademark Office announced the availability of extensions to the time allowed to file certain patent-related documents and to pay certain required fees. The...more

Impact of COVID-19 Pandemic on Patent Offices and Federal Courts – April 2 UPDATE

On March 11, World Health Organization Director-General Tedros Adhanom declared that the COVID-19 outbreak "can be characterized as a pandemic," cautioning that the WHO has "rung the alarm bell loud and clear." At the time...more

Impact of COVID-19 Pandemic on Patent Offices and Federal Courts -- March 26 UPDATE

On March 11, World Health Organization Director-General Tedros Adhanom declared that the COVID-19 outbreak "can be characterized as a pandemic," cautioning that the WHO has "rung the alarm bell loud and clear."  At the time...more

Impact of COVID-19 Pandemic on Patent Offices and Federal Courts -- March 19 UPDATE

Last week, World Health Organization Director-General Tedros Adhanom declared that the COVID-19 outbreak "can be characterized as a pandemic," cautioning that the WHO has "rung the alarm bell loud and clear."  At the time of...more

Impact of COVID-19 Pandemic on Patent Offices and Federal Courts -- UPDATED

On Wednesday, World Health Organization Director-General Tedros Adhanom declared that the COVID-19 outbreak "can be characterized as a pandemic," cautioning that the WHO has "rung the alarm bell loud and clear."  At the time...more

Impact of COVID-19 Pandemic on Patent Offices and Federal Courts

On Wednesday, World Health Organization Director-General Tedros Adhanom declared that the COVID-19 outbreak "can be characterized as a pandemic," cautioning that the WHO has "rung the alarm bell loud and clear."  At the time...more

USPTO Issues Clarification Regarding Petitions Based on Unintentional Delay

Last week, the U.S. Patent and Trademark Office issued a notice in the Federal Register (85 Fed. Reg. 12222), in which the Office clarified its practice with respect to those situations where the Office will require...more

USPTO Meets Pendency Goals for FY2019

On October 9, 2019, the U.S. Patent and Trademark Office announced via an e-mail to its stakeholders and in a post on the Director's Form Blog that the Office had achieved its long-term goals of reducing first action pendency...more

10/10/2019  /  Patent Applications , Patents , USPTO

Honeywell Int'l v. Arkema Inc. (Fed. Cir. 2019)

On October 1, 2019, in Honeywell Int'l v. Arkema Inc., the Federal Circuit vacated a combined Final Written Decision by the U.S. Patent and Trademark Office Patent Trial and Appeal Board in two post-grant review proceedings...more

Intra-Cellular Therapies, Inc. v. Iancu (Fed. Cir. 2019)

Last week, in Intra-Cellular Therapies, Inc. v. Iancu, the Federal Circuit affirmed a decision by the U.S. District Court for the Eastern District of Virginia affirming a determination by the U.S. Patent and Trademark Office...more

Mayo Foundation for Medical Education and Research v. Iancu (Fed. Cir. 2019)

On Monday, September 16, 2019, in Mayo Foundation for Medical Education and Research v. Iancu, the Federal Circuit affirmed a decision by the U.S. District Court for the Eastern District of Virginia affirming a determination...more

Amgen Inc. v. Coherus BioSciences Inc. (Fed. Cir. 2019)

Last month, in Amgen Inc. v. Coherus BioSciences Inc., the Federal Circuit affirmed a decision by the U.S. District Court for the District of Delaware dismissing a complaint filed by Amgen Inc. and Amgen Manufacturing Ltd....more

USPTO to Accept New Applications to Ongoing IP5 CS&E Pilot

In a Patent Alert e-mail distributed last week, the U.S. Patent and Trademark Office announced that beginning July 1, 2019, the Office would once again be accepting new International applications to the IP5 Patent Cooperation...more

In re Ikeda Food Research Co. (Fed. Cir. 2019)

Last week, in In re Ikeda Food Research Co., the Federal Circuit affirmed a decision by the U.S. Patent and Trademark Office Patent Trial and Appeal Board affirming the Examiner's rejection in an ex parte reexamination of...more

WesternGeco L.L.C. v. ION Geophysical Corp. (Fed. Cir. 2019)

Last June, the Supreme Court determined that $93.4 million in lost foreign profits awarded to WesternGeco L.L.C. for infringement under 35 U.S.C. § 271(f)(2) was a permissible domestic application of 35 U.S.C. § 284, and the...more

Supernus Pharmaceuticals, Inc. v. Iancu (Fed. Cir. 2019)

Last week, in Supernus Pharmaceuticals, Inc. v. Iancu, the Federal Circuit reversed the entry of summary judgment by the District Court for the Eastern District of Virginia, which concluded that the U.S. Patent and Trademark...more

In re Tropp (Fed. Cir. 2018)

Today, December 12, 2018, in In re Tropp, the Federal Circuit vacated and remanded a decision by the U.S. Patent and Trademark Office's Patent Trial and Appeal Board affirming the Examiner's rejection of claims 29-53 of U.S....more

12/13/2018  /  Patent Applications , Patents , USPTO

FWP IP ApS v. Biogen MA, Inc. (Fed. Cir. 2018)

Last month, in FWP IP ApS v. Biogen MA, Inc., the Federal Circuit affirmed a decision by the U.S. Patent and Trademark Office's Patent Trial and Appeal Board granting Biogen's motion that FWP's U.S. Application No. 11/576,871...more

11/20/2018  /  Patent Applications , Patents , USPTO

CDC and DOD Prepare for Zombie Apocalypse

While the U.S. Patent and Trademark Office has yet to receive any patent applications describing inventions for dealing with a widespread rise of zombies (other than hi-tech "zombie" servers, virtual machines, processes,...more

Pappalardo v. Stevins (Fed. Cir. 2018)

Last week, in Pappalardo v. Stevins, the Federal Circuit affirmed-in-part, vacated-in-part, and remanded a decision by the U.S. District Court for the Middle District of Florida granting a motion to dismiss filed by...more

Otonomy, Inc. v. Auris Medical, AG (Fed. Cir. 2018)

Last week, in Otonomy, Inc. v. Auris Medical, AG, the Federal Circuit reversed the decision by the U.S. Patent and Trademark Office's Patent Trial and Appeal Board according to Auris Medical, AG the benefit of priority to its...more

Ex parte Galloway (PTAB 2018)

In a decision issued in May, the Patent Trial and Appeal Board of the U.S. Patent and Trademark Office reversed the final rejection of claims 35-48 in U.S. Application No. 13/512,585. The claims at issue had been rejected by...more

Ex parte Kotanko (PTAB 2018)

In an interesting decision issued last year, the Patent Trial and Appeal Board reversed the final rejection of claims 1-5 and 9 in U.S. Application No. 12/959,017. The claims at issue had been rejected under 35 U.S.C. § 101...more

Top Stories of 2017: #5 to #9

After reflecting upon the events of the past twelve months, Patent Docs presents its 11th annual list of top patent stories. For 2017, we identified nineteen stories that were covered on Patent Docs last year that we believe...more

84 Results
 / 
View per page
Page: of 4

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide